Cargando…

P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE

Detalles Bibliográficos
Autores principales: Harrison, C., Mascarenhas, J., Abraham, P., Nadal, J. A., Balanean, A., McBride, A., Kish, J. K., Liassou, D., Feinberg, B. A., Gerds, A. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431248/
http://dx.doi.org/10.1097/01.HS9.0000847096.24450.eb
_version_ 1784780001268203520
author Harrison, C.
Mascarenhas, J.
Abraham, P.
Nadal, J. A.
Balanean, A.
McBride, A.
Kish, J. K.
Liassou, D.
Feinberg, B. A.
Gerds, A. T.
author_facet Harrison, C.
Mascarenhas, J.
Abraham, P.
Nadal, J. A.
Balanean, A.
McBride, A.
Kish, J. K.
Liassou, D.
Feinberg, B. A.
Gerds, A. T.
author_sort Harrison, C.
collection PubMed
description
format Online
Article
Text
id pubmed-9431248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94312482022-08-31 P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE Harrison, C. Mascarenhas, J. Abraham, P. Nadal, J. A. Balanean, A. McBride, A. Kish, J. K. Liassou, D. Feinberg, B. A. Gerds, A. T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431248/ http://dx.doi.org/10.1097/01.HS9.0000847096.24450.eb Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Harrison, C.
Mascarenhas, J.
Abraham, P.
Nadal, J. A.
Balanean, A.
McBride, A.
Kish, J. K.
Liassou, D.
Feinberg, B. A.
Gerds, A. T.
P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title_full P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title_fullStr P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title_full_unstemmed P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title_short P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
title_sort p1057: real-world utilization of fedratinib for myelofibrosis following ruxolitinib failure
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431248/
http://dx.doi.org/10.1097/01.HS9.0000847096.24450.eb
work_keys_str_mv AT harrisonc p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT mascarenhasj p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT abrahamp p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT nadalja p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT balaneana p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT mcbridea p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT kishjk p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT liassoud p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT feinbergba p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure
AT gerdsat p1057realworldutilizationoffedratinibformyelofibrosisfollowingruxolitinibfailure